A grade III or grade IV glioma arising from the central nervous system. This category includes glioblastoma, anaplastic astrocytoma, anaplastic ependymoma, anaplastic oligodendroglioma, and anaplastic...
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
The documentation surrounding malignant glioma is limited due to its complex nature and the fact that it affects a relatively small population compared to other cancers. The lack of identified genetic causes and systematic studies contributes to the challenges in understanding the full spectrum of clinical features associated with this condition. Ongoing research aims to enhance our understanding and treatment options.
To navigate your care effectively, consider consulting with a neuro-oncologist who specializes in brain tumors. They can provide insights into the latest treatment options and clinical trials. Additionally, you can explore resources such as the National Cancer Institute (cancer.gov) for information on ongoing research and treatment strategies. Although there are no specific patient organizations identified for malignant glioma, participating in clinical trials may also connect you with other patients and support networks.
There are several orphan drugs approved for the treatment of malignant glioma, including bevacizumab and temozolomide. Additionally, there are numerous drugs in development, such as novel immunotherapies and targeted agents. With 277 active clinical trials currently underway, patients have opportunities to participate in cutting-edge research. For more information on available trials, visit ClinicalTrials.gov: https://clinicaltrials.gov/search?cond=malignant%20glioma.
Actionable guidance for navigating care for malignant glioma
To navigate your care effectively, consider consulting with a neuro-oncologist who specializes in brain tumors. They can provide insights into the latest treatment options and clinical trials. Additionally, you can explore resources such as the National Cancer Institute (cancer.gov) for information on ongoing research and treatment strategies. Although there are no specific patient organizations identified for malignant glioma, participating in clinical trials may also connect you with other patients and support networks.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
Consider asking your healthcare providers these condition-specific questions
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Organizations with approved therapies for this disease
No approved therapies yet
Research is ongoing — 118 companies have orphan drug designations for this disease
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.